Dose-dependent suppression of adrenocortical activity with metyrapone: effects on emotion and memory - PubMed (original) (raw)
Dose-dependent suppression of adrenocortical activity with metyrapone: effects on emotion and memory
B Roozendaal et al. Psychoneuroendocrinology. 1996 Nov.
Abstract
Different levels of circulating corticosterone are considered to produce different emotional states and effects on learning and memory. The purpose of the present study was to use different doses of the 11-beta-hydroxylase inhibitor metyrapone to produce dose-dependent inhibition of the synthesis of corticosterone and examine the consequences of that on several cognitive and emotional parameters. Systemic (SC) injections of metyrapone (25 or 50 mg/kg) dose-dependently suppressed increases in plasma concentrations of corticosterone induced by spatial training in a water maze, but did not affect plasma corticosterone levels in non-stressed rats. Treatment with the higher and lower dose of metyrapone also differentially affected behavioral measures of emotion and memory. Administration of 50 mg/kg, but not 25 mg/kg, of metyrapone impaired acquisition performance in the spatial water maze task. Both doses of metyrapone impaired retention. The impairment in retention was attenuated by dexamethasone (0.3 mg/kg) given systemically immediately after training, but not by corticosterone (0.3 mg/kg). During the exposure to a conditioned stressor of inescapable footshock, the higher, but not the lower dose of metyrapone attenuated fear-induced immobility. In contrast, the lower, but not the higher dose attenuated the anxiety state in an elevated plus-maze in a novel environment immediately after exposure to the conditioned stressor. It is suggested that emotion, learning, and memory are differentially affected by the different doses of metyrapone due to interference with different types of adrenal steroid receptors and consequent induction of various corticosterone receptor states.
Similar articles
- Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine.
Roozendaal B, Carmi O, McGaugh JL. Roozendaal B, et al. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1429-33. doi: 10.1073/pnas.93.4.1429. Proc Natl Acad Sci U S A. 1996. PMID: 8643648 Free PMC article. - Glucocorticoids mediate stress-induced impairment of retrieval of stimulus-response memory.
Atsak P, Guenzel FM, Kantar-Gok D, Zalachoras I, Yargicoglu P, Meijer OC, Quirarte GL, Wolf OT, Schwabe L, Roozendaal B. Atsak P, et al. Psychoneuroendocrinology. 2016 May;67:207-15. doi: 10.1016/j.psyneuen.2016.02.006. Epub 2016 Feb 11. Psychoneuroendocrinology. 2016. PMID: 26923851 - Memory enhancement of classical fear conditioning by post-training injections of corticosterone in rats.
Hui GK, Figueroa IR, Poytress BS, Roozendaal B, McGaugh JL, Weinberger NM. Hui GK, et al. Neurobiol Learn Mem. 2004 Jan;81(1):67-74. doi: 10.1016/j.nlm.2003.09.002. Neurobiol Learn Mem. 2004. PMID: 14670360 - Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity.
Campolongo P, Morena M, Scaccianoce S, Trezza V, Chiarotti F, Schelling G, Cuomo V, Roozendaal B. Campolongo P, et al. Neuropsychopharmacology. 2013 Jun;38(7):1276-86. doi: 10.1038/npp.2013.26. Epub 2013 Jan 22. Neuropsychopharmacology. 2013. PMID: 23340520 Free PMC article. - Metyrapone reveals that previous chronic stress differentially impairs hippocampal-dependent memory.
Conrad CD, Mauldin-Jourdain ML, Hobbs RJ. Conrad CD, et al. Stress. 2001 Dec;4(4):305-18. doi: 10.3109/10253890109014754. Stress. 2001. PMID: 18301732 Free PMC article.
Cited by
- Emotional comorbidities in epilepsy result from seizure-induced corticosterone activity.
Gom RC, George AG, Harris SA, Wickramarachchi P, Bhatt D, Acharjee S, Pittman QJ, Hill MN, Colangeli R, Teskey GC. Gom RC, et al. Neurobiol Stress. 2024 Oct 11;33:100678. doi: 10.1016/j.ynstr.2024.100678. eCollection 2024 Nov. Neurobiol Stress. 2024. PMID: 39497812 Free PMC article. - Stress within a restricted time window selectively affects the persistence of long-term memory.
Yang C, Liu JF, Chai BS, Fang Q, Chai N, Zhao LY, Xue YX, Luo YX, Jian M, Han Y, Shi HS, Lu L, Wu P, Wang JS. Yang C, et al. PLoS One. 2013;8(3):e59075. doi: 10.1371/journal.pone.0059075. Epub 2013 Mar 27. PLoS One. 2013. PMID: 23544051 Free PMC article. - Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs.
Marchetta E, Mancini GF, Morena M, Campolongo P. Marchetta E, et al. Curr Neuropharmacol. 2023;21(3):687-707. doi: 10.2174/1570159X21666221207162750. Curr Neuropharmacol. 2023. PMID: 36503450 Free PMC article. Review. - Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis.
Marissal-Arvy N, Moisan MP. Marissal-Arvy N, et al. Metabol Open. 2022 Jul 31;15:100202. doi: 10.1016/j.metop.2022.100202. eCollection 2022 Sep. Metabol Open. 2022. PMID: 35958117 Free PMC article. Review. - Corticosterone influences on Mammalian neonatal sensitive-period learning.
Moriceau S, Sullivan RM. Moriceau S, et al. Behav Neurosci. 2004 Apr;118(2):274-81. doi: 10.1037/0735-7044.118.2.274. Behav Neurosci. 2004. PMID: 15113251 Free PMC article.